Severe agranulocytosis in patient with Graves’ disease on second exposure to carbimazole

Key Points

• The aim is to analyze the occurrence of agranulocytosis in a patient with Graves’ disease after exposure to carbimazole.
• Case report of a patient with Graves' disease
• Analysis of agranulocytosis symptoms and management
• Discussion on the timing of drug exposure and effects
• The patient developed severe agranulocytosis after a second exposure to carbimazole.
• Surgery was required for management due to life-threatening nature of the condition.
• Emphasis on patient education about symptoms of agranulocytosis.